The Notch gene encodes a heterodimeric transmembrane receptor whose structure is highly conserved among diverse multicellular organisms including flies, worms, mice, and humans. The Notch receptor is expressed on the surface of many cell types, and signals received through this receptor play an important role in diverse developmental and cellular processes including proliferation, differentiation, survival, and apoptosis. During normal mammalian lymphoid development, Notch signals are exquisitely regulated at multiple levels to direct the proper, stepwise maturation of T cells. Dysregulated Notch signaling, however, results in neoplastic transformation of T lymphoid progenitors, and causes pre-T acute lymphoblastic leukemia (T-ALL) in both humans and mice. Although activating mutations of the Notch receptor are relatively rare among human T-ALLs, many of these tumors derive from early stages of T cell development during which critical components of the Notch signaling pathway are expressed and functionally integrated. ? ? The goals of this proposal are to determine how dysregulation of the Notch signaling pathway leads to neoplastic transformation of T cell progenitors, and to determine if Notch signaling may play a broader role in the pathogenesis of human T-ALL than is currently appreciated. These studies will make use of novel small molecule and peptide inhibitors to modulate Notch signaling in cultured human and mouse cell lines, with validation of in vitro findings using animal models. Furthermore, hypotheses generated in the experimental setting will also be addressed using existing primary human tumor material obtained from discarded pathologic specimens. This work will yield novel insights into the multistep process of oncogenic transformation, particularly with respect to T lymphoid progenitors, and will generate findings that have potential for direct clinical application in the treatment of acute T cell leukemias. ? ? The specific aims of this proposal are: 1) to define Notch signaling events that are important for T cell transformation, and 2) to ascertain the role of Notch signaling in a broad range of human T-ALLs. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Career Transition Award (K22)
Project #
5K22CA112538-02
Application #
7238633
Study Section
Subcommittee G - Education (NCI)
Program Officer
Jakowlew, Sonia B
Project Start
2006-07-01
Project End
2009-06-30
Budget Start
2007-07-24
Budget End
2008-06-30
Support Year
2
Fiscal Year
2007
Total Cost
$160,920
Indirect Cost
Name
British Columbia Cancer Agency
Department
Type
DUNS #
209137736
City
Vancouver
State
BC
Country
Canada
Zip Code
V5 1-L3
Giambra, Vincenzo; Jenkins, Christopher R; Wang, Hongfang et al. (2012) NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-? and reactive oxygen species. Nat Med 18:1693-8
Medyouf, Hind; Gusscott, Samuel; Wang, Hongfang et al. (2011) High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J Exp Med 208:1809-22
Medyouf, Hind; Gao, Xiuhua; Armstrong, Florence et al. (2010) Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss. Blood 115:1175-84